Fusion proteins which act on the OX40/TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, and alloimmune diseases, as well as cancer.

Edits on 24 May, 2023

"update inverses"

Golden AI

edited on 24 May, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11654180 Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

Edits on 22 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 22 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=09221895

"Remove leading 0 from patent number"

Golden AI

edited on 22 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09221895 OX40/TRAIL fusion proteins US Patent 9221895 OX40/TRAIL fusion proteins

Infobox

Patent Number

09221895

Patent Number

9221895

Edits on 17 Jun, 2022

"Entity importer update"

Golden AI

edited on 17 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09221895

Edits on 4 Jan, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 4 Jan, 2022

Edits made to:

Infobox (+7 properties)

‌

US Patent 09221895 OX40/TRAIL fusion proteins

Infobox

Is a

Patent

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09221895

Date of patent

December 29, 2015

Patent application number

13256401

Date Filed

March 11, 2010

Patent primary examiner

‌

Anand Desai

Find more entities like US Patent 9221895 OX40/TRAIL fusion proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API